Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action degraders, inhibitors |
Mechanism HDAC6 degraders(Histone deacetylase 6 degraders), HDAC6 inhibitors(Histone deacetylase 6 inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC38H41N9O8 |
InChIKeyBLNDIBWEUOPBJC-UHFFFAOYSA-N |
CAS Registry2408840-13-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | United States | 04 Jul 2019 |